SENNA SYRUP- sennosides liquid 
Rising Pharma Holdings, Inc.

----------

Senna Syrup

Active ingredient

(in each 5 mL teaspoonful)

Sennosides - 8.8 mg

Purpose

Laxative

Uses

Warnings

Do not use laxative products for longer than 1 week unless directed by a doctor.

Ask a doctor before use if you have

Stope use and ask a doctor if you have rectal bleeding or failure to have a bowel movement after use of laxative. These may indicate a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of accidental overdose, get medical help or contact a Poison Control Center immediately.

Directions

AgeStarting DoseMaximum Dose
 adults and children 12 years and older 2 to 3 teaspoonfuls once a day preferably at bedtime; increase as needed or as recommended by a doctor3 teaspoonfuls in the morning and 3 teaspoonfuls at bedtime
Under 12 years of age ask a doctor ask a doctor

Other information

TAMPER-EVIDENT: Do not use if foil seal over bottle opening is torn, broken, or missing.

Inactive ingredients:artificial and natural chocolate flavor, methylparaben, propylene glycol, propylparaben, purified water, sucrose.

Questions or comments?

Call 1-844-474-7464

sennalabel01

SENNA SYRUP 
sennosides liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:57237-301
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.8 mg  in 5 mL
Inactive Ingredients
Ingredient NameStrength
METHYLPARABEN (UNII: A2I8C7HI9T)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
WATER (UNII: 059QF0KO0R)  
SUCROSE (UNII: C151H8M554)  
Product Characteristics
Colorbrown (Brown to dark brown) Score    
ShapeSize
FlavorCHOCOLATEImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:57237-301-24237 mL in 1 BOTTLE; Type 0: Not a Combination Product09/27/2022
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM007.6009/27/2022
Labeler - Rising Pharma Holdings, Inc. (116880195)
Establishment
NameAddressID/FEIBusiness Operations
Invahealth Inc.116840615analysis(57237-301) , label(57237-301) , manufacture(57237-301) , pack(57237-301)

Revised: 10/2024
Document Id: 72024c96-34c8-40af-b26a-147f0e7d4f0a
Set id: dc636b83-6eca-412e-bac5-0c736b371ca7
Version: 2
Effective Time: 20241018
 
Rising Pharma Holdings, Inc.